Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ROUTLEDGE C' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 41 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bromidge, SM; Griffith, K; Heightman, TD; Jennings, A; King, FD; Moss, SF; Newman, H; Riley, G; Routledge, C; Serafinowska, HT; Thomas, DR
      Novel (4-piperazin-1-ylquinolin-6-yl) arylsulfonamides with high affinity and selectivity for the 5-HT6 receptor

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    2. Bromidge, SM; Clarke, SE; Gager, T; Griffith, K; Jeffrey, P; Jennings, AJ; Joiner, GF; King, FD; Lovell, PJ; Moss, SF; Newman, H; Riley, G; Rogers, D; Routledge, C; Serafinowska, H; Smith, DR
      Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: Identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Jones, DNC; Gartlon, J; Parker, F; Taylor, SG; Routledge, C; Hemmati, P; Munton, RP; Ashmeade, TE; Hatcher, JP; Johns, A; Porter, RA; Hagan, JJ; Hunter, AJ; Upton, N
      Effects of centrally administered orexin-1 and orexinA: a role for orexin-1 receptors in orexin-B-induced hyperactivity

      PSYCHOPHARMACOLOGY
    4. Roberts, C; Hatcher, P; Hagan, JJ; Austin, NE; Jeffrey, P; Wyman, P; Gaster, LM; Routledge, C; Middlemiss, DN
      The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, onin vivo extracellular 5-HT levels in the freely-moving guinea-pig

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    5. Reavill, C; Taylor, SG; Wood, MD; Ashmeade, T; Austin, NE; Avenell, KY; Boyfield, I; Branch, CL; Cilia, J; Coldwell, MC; Hadley, MS; Hunter, AJ; Jeffrey, P; Jewitt, F; Johnson, CN; Jones, DNC; Medhurst, AD; Middlemiss, DN; Nash, DJ; Riley, GJ; Routledge, C; Stemp, G; Thewlis, KM; Trail, B; Vong, AKK; Hagan, JJ
      Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Stemp, G; Ashmeade, T; Branch, CL; Hadley, MS; Hunter, AJ; Johnson, CN; Nash, DJ; Thewlis, KM; Vong, AKK; Austin, NE; Jeffrey, P; Avenell, KY; Boyfield, I; Hagan, JJ; Middlemiss, DN; Reavill, C; Riley, GJ; Routledge, C; Wood, M
      Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D-3 receptor antagonist with high oral bioavailability and CNS penetration in the rat

      JOURNAL OF MEDICINAL CHEMISTRY
    7. Hirst, WD; Minton, JAL; Bromidge, SM; Moss, SF; Latter, AJ; Riley, G; Routledge, C; Middlemiss, DN; Price, GW
      Characterization of [I-125]-SB-258585 binding to human recombinant and native 5-HT6 receptors in rat, pig and human brain tissue

      BRITISH JOURNAL OF PHARMACOLOGY
    8. Routledge, C; Bromidge, SM; Moss, SF; Price, GW; Hirst, W; Newman, H; Riley, G; Gager, T; Stean, T; Upton, N; Clarke, SE; Brown, AM; Middlemiss, DN
      Characterization of SB-271046: A potent, selective and orally active 5-HT6receptor antagonist

      BRITISH JOURNAL OF PHARMACOLOGY
    9. Shah, AJ; de Biasi, V; Taylor, SG; Roberts, C; Hemmati, P; Munton, R; West, A; Routledge, C; Camilleri, P
      Development of a protocol for the automated analysis of amino acids in brain tissue samples and microdialysates

      JOURNAL OF CHROMATOGRAPHY B
    10. Roberts, C; Boyd, DF; Middlemiss, DN; Routledge, C
      Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HTre-uptake site blockade

      NEUROPHARMACOLOGY
    11. Hagan, JJ; Leslie, RA; Patel, S; Evans, ML; Wattam, TA; Holmes, S; Benham, CD; Taylor, SG; Routledge, C; Hemmati, P; Munton, RP; Ashmeade, TE; Shah, AS; Hatcher, JP; Hatcher, PD; Jones, DNC; Smith, MI; Piper, DC; Hunter, AJ; Porter, RA; Upton, N
      Orexin A activates locus coeruleus cell firing and increases arousal in the rat

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    12. Bromidge, SM; Brown, AM; Clarke, SE; Dodgson, K; Gager, T; Grassam, HL; Jeffrey, PM; Joiner, GF; King, FD; Middlemiss, DN; Moss, SF; Newman, H; Riley, G; Routledge, C; Wyman, P
      5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): A potent, selective, and orally bioavailable 5-HT6 receptor antagonist

      JOURNAL OF MEDICINAL CHEMISTRY
    13. GASTER LM; BLANEY FE; DAVIES S; DUCKWORTH DM; HAM P; JENKINS S; JENNINGS AJ; JOINER GF; KING FD; MULHOLLAND KR; WYMAN PA; HAGAN JJ; HATCHER J; JONES BJ; MIDDLEMISS DN; PRICE GW; RILEY G; ROBERTS C; ROUTLEDGE C; SELKIRK J; SLADE PD
      THE SELECTIVE 5-HT1B RECEPTOR INVERSE AGONIST TETRAHYDROSPIRO[FURO[2,3-F]INDOLE-3,4'-PIPERIDINE] (SB-224289) POTENTLY BLOCKS TERMINAL 5-HT AUTORECEPTOR FUNCTION BOTH IN-VITRO AND IN-VIVO

      Journal of medicinal chemistry
    14. ROBERTS C; BELENGUER A; MIDDLEMISS DN; ROUTLEDGE C
      DIFFERENTIAL-EFFECTS OF 5-HT1B (1D) RECEPTOR ANTAGONISTS IN DORSAL AND MEDIAN RAPHE INNERVATED BRAIN-REGIONS/

      European journal of pharmacology
    15. Routledge, C
      Egypt in the age of the pyramids.

      CLASSICAL WORLD
    16. Routledge, C
      The Egyptians.

      CLASSICAL WORLD
    17. Routledge, C
      A dictionary of ancient Egypt.

      CLASSICAL WORLD
    18. Routledge, C
      The ancient Near-East c. 3000-330 BC, vols 1 and 2.

      CLASSICAL WORLD
    19. ASHMEADE T; ROUTLEDGE C
      THE ROLE OF 5-HT1B, RECEPTORS IN THE MODULATION OF PLASMA ACTH LEVELS

      British Journal of Pharmacology
    20. ROUTLEDGE C
      A MATTER OF DISGUISE - LOCATING THE SELF IN CHANDLER,RAYMOND THE 'BIGSLEEP' AND THE 'LONG GOOD-BYE'

      Studies in the novel
    21. THORN L; ASHMEADE TE; STOREY VJ; ROUTLEDGE C; REAVILL C
      EVIDENCE TO SUGGEST THAT AGONIST MODULATION OF HYPERLOCOMOTION IS VIAPOSTSYNAPTIC DOPAMINE D-2 OF D-3 RECEPTORS

      Neuropharmacology
    22. ROBERTS C; PRICE GW; GASTER L; JONES BJ; MIDDLEMISS DN; ROUTLEDGE C
      IMPORTANCE OF H5-HT1B RECEPTOR SELECTIVITY FOR 5-HT TERMINAL AUTORECEPTOR ACTIVITY - AN IN-VIVO MICRODIALYSIS STUDY IN THE FREELY-MOVING GUINEA-PIG

      Neuropharmacology
    23. ROBERTS C; BELENGUER A; MIDDLEMISS DN; ROUTLEDGE C
      COMPARISON OF 5-HT AUTORECEPTOR CONTROL IN GUINEA-PIG DORSAL AND MEDIAN RAPHE INNERVATED BRAIN-REGIONS

      British Journal of Pharmacology
    24. TAYLOR SG; PATEL SR; ROBERTS JC; ROUTLEDGE C
      REPEATED MICRODIALYSIS EXPERIMENTS IN THE RAT STRIATUM OF CONSCIOUS RATS - EFFECTS OF QUINELORANE ON DOPAMINE RELEASE

      British Journal of Pharmacology
    25. ROBERTS C; PRICE GW; JONES BJ; MIDDLEMISS DN; GASTER L; ROUTLEDGE C
      IMPORTANCE OF 5-HT1B SELECTIVITY FOR 5-HT TERMINAL AUTORECEPTOR ACTIVITY - AN IN-VIVO MICRODIALYSIS STUDY IN THE FREELY-MOVING GUINEA-PIG

      British Journal of Pharmacology
    26. THORN L; ROUTLEDGE C
      COMPARATIVE MODULATION OF HIPPOCAMPAL 5-HT RELEASE BY THE 5-HT2C RECEPTOR ANTAGONIST SB-206553 AND PAROXETINE

      British Journal of Pharmacology
    27. ROUTLEDGE C
      THE ARCHAEOLOGY OF DEATH IN THE ANCIENT NEAR-EAST - CAMPBELL,S, GREEN,A

      The Biblical archaeologist
    28. ROUTLEDGE C; MIDDLEMISS DN
      THE 5-HT HYPOTHESIS OF DEPRESSION REVISITED

      Molecular psychiatry
    29. ROUTLEDGE C; THORN L; ASHMEADE T; TAYLOR S
      ELUCIDATION OF D-3 RECEPTOR FUNCTION IN-VIVO - DO D-3 RECEPTORS MEDIATE INHIBITION OF DOPAMINE NEURONAL-ACTIVITY

      Biochemical Society transactions
    30. TAYLOR SG; ROUTLEDGE C
      LACK OF EFFECT OF SYSTEMICALLY ADMINISTERED 5-HT4 AGONISTS ON DOPAMINE LEVELS MEASURED FROM THE NUCLEUS-ACCUMBENS AND STRIATUM - AN IN-VIVOMICRODIALYSIS STUDY IN FREELY-MOVING

      British Journal of Pharmacology
    31. ROUTLEDGE C
      DEVELOPMENT OF 5-HT1A RECEPTOR ANTAGONISTS

      Behavioural brain research
    32. ROUTLEDGE C; GURLING J; ASHWORTHPREECE MA; DOURISH CT
      DIFFERENTIAL-EFFECTS OF WAY-100135 ON THE DECREASE IN 5-HYDROXYTRYPTAMINE RELEASE INDUCED BY BUSPIRONE AND NAN-190

      European journal of pharmacology
    33. DAWSON LA; ROUTLEDGE C
      DIFFERENTIAL-EFFECTS OF POTASSIUM CHANNEL BLOCKERS ON EXTRACELLULAR CONCENTRATIONS OF DOPAMINE AND 5-HT IN THE STRIATUM OF CONSCIOUS RATS

      British Journal of Pharmacology
    34. ROUTLEDGE C
      PILLARED BUILDINGS IN IRON-AGE MOAB

      The Biblical archaeologist
    35. DAWSON LA; STOW JM; DOURISH CT; ROUTLEDGE C
      ANALYSIS OF GLUTAMATE IN STRIATAL MICRODIALYSATES USING CAPILLARY ELECTROPHORESIS AND LASER-INDUCED FLUORESCENCE DETECTION

      Journal of chromatography
    36. ROUTLEDGE C; HARTLEY J; GURLING J; ASHWORTHPREECE M; BROWN G; DOURISH CT
      IN-VIVO CHARACTERIZATION OF THE PUTATIVE 5-HT1A RECEPTOR ANTAGONIST SDZ-216,525 USING 2 MODELS OF SOMATODENDRITIC 5-HT1A RECEPTOR FUNCTION

      Neuropharmacology
    37. DAWSON L; ROUTLEDGE C
      EFFECTS OF POTASSIUM CHANNEL BLOCKERS ON EXTRACELLULAR LEVELS OF SEROTONIN AND DOPAMINE IN THE STRIATUM OF CONSCIOUS RATS - A MICRODIALYSISSTUDY

      British Journal of Pharmacology
    38. GURLING J; ASHWORTHPREECE MA; DOURISH CT; ROUTLEDGE C
      EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH THE SELECTIVE 5-HT1A RECEPTOR ANTAGONIST WAY-100635 ON HIPPOCAMPAL 5-HT RELEASE IN-VIVO

      British Journal of Pharmacology
    39. THOMPSON J; MARSICO T; KATHRYN EL; MAY L; MIDDLETON J; SPEARS G; VAUGHEY BC; KELEHER K; BALDWIN K; FLEMING N; ROUTLEDGE C; SULLIVAN N; STANTON ME; MCDERMOTT J; ULRICH S; WILLIAMS D; NITZSCHE R; STIVERS S
      THE ACNMS VISIONARY PLANNING

      Journal of nurse-midwifery
    40. CLIFFE IA; BRIGHTWELL CI; FLETCHER A; FORSTER EA; MANSELL HL; REILLY Y; ROUTLEDGE C; WHITE AC
      METHOXYPHENYL)-PIPERAZIN-1-YL)-2-PHENYLPROPANAMIDE [(S)-WAY-100135] -A SELECTIVE ANTAGONIST AT PRESYNAPTIC AND POSTSYNAPTIC 5-HT(1A) RECEPTORS

      Journal of medicinal chemistry
    41. ROUTLEDGE C; GURLING J; WRIGHT IK; DOURISH CT
      NEUROCHEMICAL PROFILE OF THE SELECTIVE AND SILENT 5-HT(1A) RECEPTOR ANTAGONIST WAY100135 - AN IN-VIVO MICRODIALYSIS STUDY

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 19:21:46